SANJIVINPharmaceuticals

Sanjivani Paranteral LtdQuarterly Results & Earnings

132.75
-4.83%
Profit Growth YoY-28.70%Latest quarter
Sales Growth YoY-14.51%Latest quarter
Sales CAGR 5Y33.89%5 year compound
Profit CAGR 5Y46.45%5 year compound
📋

Quarterly Performance

YoY Profit Growth-28.70%
🔴 Significant decline
YoY Sales Growth-14.51%
🔴 Significant decline
OPM 5Y Average
Operating profit margin
14.49%
EPS Growth 5Y
34.19%
Interest Coverage
Higher = safer debt servicing
15.64
ROE
24.58%
ROCE
30.21%
💡

Growth Analysis

Sanjivani Paranteral Ltd reported YoY profit growth of -28.70% and revenue growth of -14.51% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 33.89% and profits at 46.45% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.